Doreen McMorran - Ovation Science COO VP
| OVATF Stock | USD 0.01 0.02 64.81% |
Insider
Doreen McMorran is COO VP of Ovation Science
| Age | 61 |
| Phone | 604 283 0903 |
| Web | https://ovationscience.com |
Ovation Science Management Efficiency
The company has return on total asset (ROA) of (0.7361) % which means that it has lost $0.7361 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.884) %, meaning that it generated substantial loss on money invested by shareholders. Ovation Science's management efficiency ratios could be used to measure how well Ovation Science manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Mathew Faulkner | Green Thumb Industries | 50 | |
| Yifat Esq | Kamada | 47 | |
| Rebecca Young | Trulieve Cannabis Corp | 42 | |
| Edward Kremer | Curaleaf Holdings | 51 | |
| Erica CPA | Biofrontera | 39 | |
| Linda Marsicano | Green Thumb Industries | 55 | |
| Jakob Feinstein | Curaleaf Holdings | N/A | |
| Joe Holland | Curaleaf Holdings | N/A | |
| Mark Baldyga | Biofrontera | N/A | |
| Ariella Raban | Kamada | 48 | |
| Jason Pernell | Trulieve Cannabis Corp | 45 | |
| Matthew Darin | Curaleaf Holdings | N/A | |
| Jason Finkelstein | Rockwell Medical | N/A | |
| Christine Hersey | Trulieve Cannabis Corp | N/A | |
| Albert Bolles | Lifecore Biomedical | 66 | |
| Marc MD | Rockwell Medical | 63 | |
| Swadheen Sehgal | Green Thumb Industries | N/A | |
| Alex CPA | Trulieve Cannabis Corp | 48 | |
| Peter JD | Curaleaf Holdings | 55 | |
| JD III | Trulieve Cannabis Corp | 54 | |
| Joseph Bayern | Curaleaf Holdings | 60 | |
Management Performance
| Return On Equity | -1.88 | |||
| Return On Asset | -0.74 |
Ovation Science Leadership Team
Elected by the shareholders, the Ovation Science's board of directors comprises two types of representatives: Ovation Science inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Ovation. The board's role is to monitor Ovation Science's management team and ensure that shareholders' interests are well served. Ovation Science's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Ovation Science's outside directors are responsible for providing unbiased perspectives on the board's policies.
| BCom ACA, S CFO | ||
| David Ryan, Head Director | ||
| Terry Howlett, CEO Pres | ||
| Doreen McMorran, COO VP |
Ovation Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Ovation Science a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.88 | |||
| Return On Asset | -0.74 | |||
| Operating Margin | (11.43) % | |||
| Current Valuation | 537.31 K | |||
| Shares Outstanding | 29.37 M | |||
| Shares Owned By Insiders | 28.64 % | |||
| Price To Book | 10.86 X | |||
| Price To Sales | 4.87 X | |||
| Revenue | 224.95 K | |||
| Gross Profit | 520.79 K |
Currently Active Assets on Macroaxis
Other Information on Investing in Ovation Pink Sheet
Ovation Science financial ratios help investors to determine whether Ovation Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ovation with respect to the benefits of owning Ovation Science security.